Figure 2
From: Early toxicity predicts long-term survival in high-grade glioma
Overall survival stratified by the use of chemotherapy. Of note, 93% of subjects who received chemotherapy received BCNU. All patients who did not receive chemotherapy did receive a systemic agent (temozolomide, diaziquone, tamoxifen, thalidomide or β-interferon).
